Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

USP22 Suppresses Trophoblast Cell Necroptosis in Preeclampsia by Stabilizing KAT2A-Mediated Histone Acetylation at the SFRP1 Promoter

ABSTRACT: This study investigates the role of USP22 in trophoblast necroptosis and preeclampsia (PE). USP22 expression was significantly downregulated in PE placental tissues, accompanied by elevated necroptosis markers RIPK1, RIPK3, and MLKL. A hypoxic HTR-8/SVneo trophoblast cell model recapitulated the PE microenvironment, where necroptosis was confirmed as the dominant death modality. USP22 knockdown exacerbated necroptotic signaling, while USP22 overexpression restored H3K9ac and H3K27ac levels and suppressed necroptosis. RNA-seq identified 1,186 differentially expressed genes upon USP22 knockdown, including marked repression of the Wnt antagonist SFRP1. Mechanistically, USP22 directly interacted with KAT2A and stabilized it via selective removal of K48-linked polyubiquitin chains, sustaining KAT2A-dependent histone acetylation at the SFRP1 promoter to maintain SFRP1 transcription. SFRP1 restoration in USP22-deficient trophoblasts reduced cell death and decreased p-MLKL/MLKL ratio. The L-NAME rat PE model confirmed coordinated downregulation of USP22, KAT2A, SFRP1, and histone acetylation in vivo.

ORGANISM(S): Homo sapiens

PROVIDER: GSE327405 | GEO | 2026/07/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

USP22 Suppresses Trophoblast Cell Necroptosis in Preeclampsia by Stabilizing KAT2A-Mediated Histone Acetylation at the SFRP1 Promoter

Project description:USP22 Suppresses Trophoblast Cell Necroptosis in Preeclampsia by Stabilizing KAT2A-Mediated Histone Acetylation at the SFRP1 Promoter

| PRJNA1450656 | ENA

Disruption of the SAGA CORE triggers collateral degradation of KAT2A

Project description:The SAGA transcriptional co-activator complex regulates gene expression through histone acetylation at promoters, mediated by its histone acetyl transferase, KAT2A. While its structure and function have been extensively investigated, how the stability of individual subunits of SAGA, including KAT2A, is regulated, remains unclear. Here, using a fluorescence-based KAT2A stability reporter, we systematically dissect the molecular dependencies controlling KAT2A protein abundance. We identify the non-enzymatic SAGA CORE module subunits—TADA1, TAF5L, and TAF6L— as necessary for KAT2A stability, with loss of these subunits disrupting the integrity of SAGA, leading to non-chromatin-bound KAT2A that is degraded by the proteasome, consequently leading to reduced H3K9 acetylation. Proteomic profiling reveals progressive loss of CORE and HAT components upon acute disruption of the SAGA CORE, indicating that an intact CORE is required for the stability of numerous components of SAGA. Finally, a focused CRISPR screen of ubiquitin-proteasome system genes identifies the E3 ligase UBR5, a known regulator of orphan protein degradation, and the deubiquitinase OTUD5, as regulators of KAT2A degradation when the SAGA CORE is perturbed. Together, these findings reveal a dependency of KAT2A protein stability on SAGA CORE integrity and define an orphan quality control mechanism targeting unassembled KAT2A, revealing a potential vulnerability in SAGA-driven malignancies.

2026-03-16 | GSE300600 | GEO

Distinct contributions of KAT2A histone acetyl-transferase complexes to human erythropoiesis

Project description:KAT2A is a histone acetyl-transferase involved in stabilization of transcriptional activity through acetylation of lysine residue 9 of Histone 3. Mouse knockout models suggest that Kat2a is dispensable for haematopoietic stem and progenitor cell activity, despite a central role in survival and maintenance of Acute Myekoid Leukaemia cells through block of differentiation. Herein, we investigate KAT2A activity in human cord blood haematopoiesis and identify a specific requirement in the establishment of the erythroid lineage. KAT2A is required for specification and survival of Erythroid-Megakaryocytic progenitors, with regulation of expression of the erythropoietin receptor (EPOR) gene, which participates in lineage commitment, as well as of later effector genes in the platelet and erythroid lineages. Early and late lineage roles can be distinctly attributed to the ATAC and SAGA complexes in which context KAT2A exerts its activity. ATAC is active earlier in erythroid lineage development and mediates MEP specification from HSC, whilst SAGA activity is required post-commitment, including in expression of haemoglobin genes. We thus position KAT2A as a novel regulator of human erythropoiesis and separate early and later effects in lineage development with complex specificity. This has implications for putative therapeutic targeting of KAT2A complexes in leukaemia.

2021-09-28 | GSE128512 | GEO

Kat2a regulates hippocampal memory formation [RNA-seq]

Project description:We sequenced mRNA from 24 samples extracted from mouse CA1 tissue to generate the first CA1-specific murine transcriptome and the first CA1-transcriptome in response to environmental novelty under normal and Kat2a-loss-of-function conditions. Samples were divded in 4 groups: A: Control naM-CM-/ve (n=6), B: control novelty-exposed (n=5), C: Kat2a cKO naM-CM-/ve (n=6), D: Kat2a cKO novelty-exposed (n=7). Pairwise comparisons for AvsB, AvsC, BvsD and CvsD were performed using DESeq2.

2014-07-16 | E-GEOD-53380 | biostudies-arrayexpress

Distinct contributions of KAT2A histone acetyl-transferase complexes to human erythropoiesis [RNA-seq]

2021-09-28 | GSE128902 | GEO

Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells [ChIP-Seq]

Project description:Identification of histone acetylation targets of Kat2a activity in murine models of acute myeloid leukemia (AML) driven by the MLL-AF9 oncogenic fusion

2020-02-03 | GSE118576 | GEO

Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells [RNA-Seq]

Project description:Identification of histone acetylation targets of Kat2a activity in murine models of acute myeloid leukaemia (AML) driven by the MLL-AF9 oncogenic fusion

2020-02-03 | GSE118768 | GEO

Kat2a regulates hippocampal memory formation [small RNA-seq]

Project description:We sequenced small RNAs from 12 samples extracted from mouse CA1 tissue to generate the first CA1-specific murine miRNome under normal and Kat2a-loss-of-function conditions. Samples were divded in 4 groups: A: Control (n=6), C: Kat2a cKO naÃ¯ve (n=6)

2014-07-16 | E-GEOD-53427 | biostudies-arrayexpress

Human 293T -cGAS-MYO1F-KAT2A,LC-MS

Project description:To identify cGAS acetylation sites, 293T cells coexpressing the PCDH-EGFP-puro empty vector or PCDH-EGFP-puro-Flag-cGAS with KAT2A and MYO1F were subjected to immunoprecipitation with an anti-Flag antibody. After washing four times with IP buffer, the protein was eluted with IP buffer containing 0.1% SDS and analyzed by mass spectrometry.

2024-12-14 | PXD057694 | Pride

SFRP1 upregulation causes hippocampal synaptic dysfunction and memory impairment

Project description:Impaired neuronal and synaptic function are hallmarks of early stages Alzheimer's disease (AD) and are linked to cognitive decline, preceding other neuropathological traits. We have previously shown that SFRP1, a glial-derived protein elevated in the brains of AD patients from preclinical stages, contributes to AD progression, suggesting that glial factors may be important for early pathogenesis. Here, we have analyzed the hippocampus of newly generated transgenic mice overexpressing SFRP1 in astrocytes. We show that SFRP1 accumulation causes early dendritic and synaptic structural defects in adult mice. These changes are followed by poor synaptic long-term potentiation and cognitive impairment, evident only when the animals age, thereby mimicking the structural-functional temporal distinction observed in AD patients. These phenotypic traits are associated with an array of proteomic changes, including increased content of structural synaptic proteins, such as neurexin, which localizes in close proximity to SFRP1 along the processes of cultured hippocampal neurons. We conclude that excessive SFRP1 prevents the turnover of structural synaptic molecules, thereby reducing synaptic plasticity —a mechanism that may mirror the synaptopathy observed in the brains of prodromal AD patients.

2026-01-19 | PXD060276 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data